MCIG mCig, Inc. Company Research Saturday, January 11, 2014 10:17:41

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
MCIG mCig, Inc. $MCIG Company Overview 

Stock Message Board http://investorshangout.com/search?q=MCIG&...mp;yt1=Go!

Last Updated: Saturday, January 11, 2014 10:17:41 PM

mCig, Inc. MCIG Current Price and Quotes
Last Price 0.205
Previous Close 0.18 Open 0.183
Daily Range 0.2074 - 0.165 52wk Range 0.26 - N/A
Volume 12,969,704 Dividend N/A
Average Vol (3m) 1,651,545 Yield N/A
mCig, Inc. MCIG
Company Information

800 Bellevue Way NE
Suite 400
Bellevue, WA 98004
Australia

Phone: 425-462-4219

mCig, Inc. MCIG
mCig, Inc. MCIG
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Oct 31, 2013 10-Q
CIK 0001525852
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7200 - Services-Personal Services
Business Status Development Stage Company a/o Nov 28, 2011
Incorporated In: NV, USA
Year of Inc. 2010
Employees 1 a/o Nov 28, 2011
Company Officers/Contacts

Paul Rosenberg President, CEO, Principal Executive Officer, CFO
Company Directors

Not Available
Company Notes

Formerly=Lifetech Industries Inc until 8-2013
Service Providers

Auditor/Accountant
De Joya Griffith & Company, LLC
2580 Anthem Village Drive
Henderson, NV, 89052
United States

Legal Counsel
Dean Law Corp.
601 Union St.
Seattle, WA, 98101
United States

Investor Relations Firm
Not Available

mCig, Inc. MCIG
MCIG Security Details

Share Structure

Market Value1 $55,368,450 a/o Jan 10, 2014
Shares Outstanding 270,090,000 a/o Oct 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  Not Available
Shareholders

Shareholders of Record Not Available
Security Notes

Capital Change=shs increased by 10 for 1 split. Payable upon surrender.. Ex-date=08/29/2013.
Short Selling Data

Short Interest 199,766 (402.34%)
Dec 31, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Island Stock Transfer

mCig, Inc. MCIG Financials
Period Ending Apr 30, 2013 Apr 30, 2012 Apr 30, 2011
Total Revenue 50 - -
Cost of Revenue - - -
Gross Profit 50 - -
Operating Expenses

Research and Development - - -
Sales, General and Admin. 155 130 23
Non-Recurring Items - - -
Other 2 - -
Operating Income (107) (130) (23)
Income From Continuing Operations

Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (107) (130) (23)
Interest Expense - - -
Earnings Before Tax (107) (130) (23)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (107) (130) (23)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (107) (130) (23)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (107) (130) (23)

mCig, Inc. MCIG Recent News

Jan 10, 2014 mCig, Inc. Officially Launches mCig 2.0 -- World's Most Affordable Personal Vaporizer
Dec 19, 2013 mCig, Inc. Provides Update on mCig 2.0 Launch
Dec 3, 2013 mCig, Inc. Provides Corporate Update -- Reduced Authorized Shares, New COO Appointment
Nov 12, 2013 mCig, Inc. Sells Out of Initial Inventory -- Provides Corporate Update
Nov 7, 2013 mCig, Inc. Now Accepting Bitcoin as Payment Method Via CoinBase
Oct 31, 2013 mCig, Inc. Officially Launches the mCig - $10 Herbal Electronic Cigarette (eCig)


MCIG mCig, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=MCIG&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/MCIG/quote
Stock Chart http://www.otcmarkets.com/stock/MCIG/chart
Company Info http://www.otcmarkets.com/stock/MCIG/company-info
Recent News http://www.otcmarkets.com/stock/MCIG/news
Financials http://www.otcmarkets.com/stock/MCIG/financials
Filings and Disclosure http://www.otcmarkets.com/stock/MCIG/filings
Short Sales http://www.otcmarkets.com/stock/MCIG/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/MCIG/insider-transactions
Research Reports http://www.otcmarkets.com/stock/MCIG/research
Summary http://finance.yahoo.com/q?s=MCIG
Historical Prices http://finance.yahoo.com/q/hp?s=MCIG+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=MCIG
Basic Chart http://finance.yahoo.com/q/bc?s=MCIG+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MCIG+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=MCIG+Headlines
Press Releases http://finance.yahoo.com/q/p?s=MCIG+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=MCIG+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=MCIG+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=MCIG+Industry
Major Holders http://finance.yahoo.com/q/mh?s=MCIG+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=MCIG+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=MCIG+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=MCIG
Balance Sheet http://finance.yahoo.com/q/bs?s=MCIG
Cash Flow http://finance.yahoo.com/q/cf?s=MCIG+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/MCIG
Market Watch http://www.marketwatch.com/investing/stock/MCIG
Bloomberg http://www.bloomberg.com/quote/MCIG:US
Morningstar http://quotes.morningstar.com/stock/s?t=MCIG
Bussinessweek http://investing.businessweek.com/research/st...icker=MCIG
Barchart http://www.barchart.com/quotes/stocks/MCIG
OTC Short Report http://otcshortreport.com/index.php?index=MCIG
Investopedia http://www.investopedia.com/markets/stocks/MCIG/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading